INDIANAPOLIS: Drugmaker Eli Lilly and Company’s SVP and chief communications officer, Kathryn Beiser, has resigned. Beiser ...
After announcing plans to build four manufacturing sites in the U.S. on Wednesday, Eli Lilly chief executive officer Dave Ricks skillfully demurred when asked if the move might forestall tariffs ...
Hosted on MSN1mon
Lilly's Chief Scientific Officer has big plans for the next generation of weight loss drugsEli Lilly's Chief Scientific Officer Dan Skovronsky says the company wants to take big swings in Alzheimer's, ALS, chronic pain and other difficult diseases after its success in obesity.
Eli Lilly Chief Executive David Ricks annual compensation rose to $29.2 million in 2024, a 10% increase from the $26.2 million he received a year earlier. Ricks' payout included $19.7 million in ...
The EU medicines regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the treatment's ability to slow cognitive ...
Eli Lilly Chief Scientific Officer Dan Skovronsky said newer obesity medicines need to deliver more than just weight loss to compete with Zepbound and Wegovy. The development of pills and more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback